Skip to main content
. 2023 Jul 25;10:1195–1206. doi: 10.2147/JHC.S418256

Figure 2.

Figure 2

Kaplan–Meier curves showing OS (A), PFS (B) and DOR (C) of each group.

Abbreviations: OS, overall survival; PFS, progression-free survival; DOR, duration of response; TACE, transarterial chemoembolization; Atezo/Bev, Atezolizumab plus Bevacizumab; LEN, lenvatinib.